Keep Me Logged In
Michel Vounatsos, Biogen CEO, talks the company's commitment to find drugs that slow the progression of Alzheimer's disease, and shares his thoughts on drug pricing.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by